Nuveen’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Sell |
|
|||||
|
2025
Q1 | $27.7M | Sell |
|
|||||
|
2024
Q4 | $24.1M | Buy |
|
|||||
|
2024
Q3 | $26.5M | Buy |
|
|||||
|
2024
Q2 | $24.6M | Sell |
|
|||||
|
2024
Q1 | $29.7M | Sell |
|
|||||
|
2023
Q4 | $28.2M | Sell |
|
|||||
|
2023
Q3 | $28M | Sell |
|
|||||
|
2023
Q2 | $32M | Buy |
|
|||||
|
2023
Q1 | $36.3M | Sell |
|
|||||
|
2022
Q4 | $40.2M | Buy |
|
|||||
|
2022
Q3 | $39.8M | Buy |
|
|||||
|
2022
Q2 | $41.2M | Buy |
|
|||||
|
2022
Q1 | $35.7M | Buy |
|
|||||
|
2021
Q4 | $36.3M | Sell |
|
|||||
|
2021
Q3 | $35.7M | Sell |
|
|||||
|
2021
Q2 | $49M | Sell |
|
|||||
|
2021
Q1 | $52.3M | Buy |
|
|||||
|
2020
Q4 | $20.3M | Buy |
|
|||||
|
2020
Q3 | $11M | Buy |
|